Urofolitrophin (Urofolitrophin) is a high purity growth hormone obtained
from the urine of menopausal people, which has the effect of promoting uterine
development and improving. Sequential administration of urinary
follicle-stimulating hormone and chorionic gonadotropin (HCG) may promote
ovulation in patients with polycystic ovary (whose LH/FSH values increase and
whose clomiphene therapy fails).
1. The key is shared with chorogonadotropin, which is used for
non-ovulatory infertility caused by insufficient gonadotropin metabolism (the
hypothalamic pituitary - pituitary function is not high or not compatible), and
is generally considered to be used for the medical cases of ovulation failure
caused by clomiphene (CC) or bromocrytine.
2. It is used with choriotropin for the treatment of primary or secondary
amenorrhea and ovarian test.
What is the action that urine promotes follicle element?
3. For polycystic ovary syndrome (PCOS), especially for patients who have
failed to use clomiphene.
4. Fertility promotion technology for all normal ovulation period of female
stimulation and superovulation period, often with clomiphene and chorotropin
with each other, can get several eggs at a time.
5. Used with choriotropin to treat men with low gonadotropin and
infertility, stimulating spermatogenesis.